BlackRock Advisors’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $3.77M | Sell |
348,599
-28,958
| -8% | -$313K | ﹤0.01% | 1194 |
|
|
2016
Q3 | $3.87M | Sell |
377,557
-449
| -0.1% | -$4.6K | ﹤0.01% | 1165 |
|
|
2016
Q2 | $4.94M | Sell |
378,006
-185,597
| -33% | -$2.42M | 0.01% | 1087 |
|
|
2016
Q1 | $6.2M | Sell |
563,603
-175,022
| -24% | -$1.93M | 0.01% | 987 |
|
|
2015
Q4 | $6.8M | Sell |
738,625
-18,636
| -2% | -$171K | 0.01% | 990 |
|
|
2015
Q3 | $5.26M | Sell |
757,261
-7,905
| -1% | -$54.9K | 0.01% | 1058 |
|
|
2015
Q2 | $7.51M | Buy |
765,166
+510,282
| +200% | +$5.01M | 0.01% | 833 |
|
|
2015
Q1 | $2.26M | Buy |
254,884
+10,974
| +4% | +$97.2K | ﹤0.01% | 1153 |
|
|
2014
Q4 | $2.14M | Sell |
243,910
-44,711
| -15% | -$392K | ﹤0.01% | 1158 |
|
|
2014
Q3 | $1.99M | Sell |
288,621
-89,466
| -24% | -$617K | ﹤0.01% | 1152 |
|
|
2014
Q2 | $1.99M | Sell |
378,087
-254,936
| -40% | -$1.34M | ﹤0.01% | 1154 |
|
|
2014
Q1 | $2.88M | Buy |
633,023
+4,052
| +0.6% | +$18.4K | ﹤0.01% | 1070 |
|
|
2013
Q4 | $3.17M | Sell |
628,971
-8,458
| -1% | -$42.6K | ﹤0.01% | 1052 |
|
|
2013
Q3 | $3.23M | Buy |
637,429
+362,742
| +132% | +$1.84M | ﹤0.01% | 1055 |
|
|
2013
Q2 | $1.36M | Buy |
+274,687
| New | +$1.36M | ﹤0.01% | 1246 |
|